Aeglea Biotherapeutics shares owned by Rafferty Asset Management
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Rafferty Asset Management
from 13F filings
Historical chart of Rafferty Asset Management investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by Rafferty Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv![Download consolidated filings csv](/static/img/csv.png)
![Download consolidated filings xlsx](/static/img/microsoft-excel.png)
Quarterly reported holdings in Aeglea Biotherapeutics by Rafferty Asset Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-12-31 | $1.8M | 77k | 23.28 |
2024-09-30 | $2.1M | 71k | 29.41 |